"Powerpoint presentations can be a good resource for a refresher course but never for primary learning": Prof. Amod Gupta

Amod GuptaPadmashri Dr. Amod Gupta, a respected teacher-of-teachers, is known all over the world. A passionate teacher and researcher, Dr. Gupta retired from Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh after an illustrious career spanning over four decades. In this interview, he replies to few of our questions asked by Dr. Tandava Krishnan.

eOphtha: You have been a teacher for more than 3 decades. You have seen the transition from bed side teaching to teaching which predominantly hinges on a power point presentation. Your thoughts on it.

Answer: Very interesting question at a time when ppt. presentations hold sway in the class room and the conference hall. There is no way a ppt. slide can substitute a bedside/clinical exam. For us in Ophthalmology ‘the bedside’ is ‘the slit lamp side’. When you examine a patient on the slit lamp, each step in the exam is preceded by a question in our mind, do I see flare? Do I see Iris atrophy?  Or do I see new vessels in the angle? When you discover what you are seeking it forms a long lasting memory. Seeing  the same sign on a power point slide is a passive phenomenon like watching  a movie, in that it  is an information in the first place you are not actually seeking, and  this unsolicited information is  likely to be lost sooner than later. Click here to read the full interview

Generic drugs: boon or a bane

Tandava Krishnan

I first heard about generic drugs 20 years ago when Cipla an Indian company came up with generic versions of antiretroviral drugs (drugs used to manage cases of HIV/AIDS). Management of HIV/AIDS, hitherto expensive and beyond the reach of many patients finally became affordable.  Health organisations like WHO which were grappling with high burden of the disease especially in African and Asian countries finally found an economical way of reducing the disease morbidity. It was a matter of pride for every Indian, especially those in the medical fraternity.  Despite such a spectacular impact, why are significant sections of doctors wary about prescribing generic drugs? Click here

7 things I wish I knew before starting private practice

Dr Deepak Garg

Private practice is one of the common answer for, what after residency/ after  fellowship questions !.   Unfortunately, even though we become brilliant ( atleast hope to ) doctors ,we sadly lack  the exposure to the  business side of the  healthcare.   Many of us either lack guidance from the right people or more frequently take advice from the other doctors  which  is from  the same perspective  I personally think it is important to keep learning different things  beyond medicine  to improve productivity and efficiency while running a successful practice  Its been 10 years since my residency and i have certainly learnt few things over this period  some of them the hard way . Click here to Read

DNB: Topic-wise Question Bank (DEC 2015 TO JUNE 2018)

Compiled by Dr. Sameeksha Agrawal

Click here to visit to questions of Ophthalmology Section


Click here to read

Five Tips for the Postgraduate to Start Publishing

fivetipsPost graduation can be a daunting task with a lot to imbibe in very little time. In ophthalmology, the science is changing ever so rapidly that a three-year residency period is almost too little to grasp the nuances of the subject. In addition to learning examination skills, you have to learn surgical skills and read literature to keep yourselves updated. Amongst all this, how do you find time to publish papers during residency? Does it really matter whether you publish any papers during this time? Are there any advantages you score over your peers if you manage to publish a few papers? Dr. Sabyasachi Sengupta shares his tips for the postgraduates. Click here to read


5 Tips To Achieve Ideal Rhexis

Pioneered and popularized by Howard Gimbel, capsulorrhexis is probably the most challenging task to learn in cataract surgery. In other words once a good rhexis is done half the battle is won. All the post-graduates and beginners struggle to do a ideal rhexis. Dr. Rohit Rao  and Dr. Charudutt Kalamkar share small tips and tricks to do rhexis better. Click here



Check out the Smart Apps for the Smart Ophthalmologists Click here

Infographics (click the image to enlarge)


Brolucizumab is a humanized single-chain antibody fragment that inhibits all isoforms of VEGF-A. It is the smallest of the anti-VEGF antibodies. Brolucizumab has a molecular weight of 26 kDa, compared with 48 kDa for ranibizumab, 115 kDa for aflibercept and 149 kDa for bevacizumab.

It is possible to concentrate brolucizumab up to 120 mg/mL, allowing the administration of 6 mg in a single 50-mL IVT injection. On a molar basis, 6 mg of brolucizumab equals approximately 12 times the 2.0-mg dose of aflibercept and 22 times the 0.5-mg dose of ranibizumab. Thus this drug has potential advantages in the treatment of ARMD. Assuming comparable half-life, higher molar doses of drug may be cleared more slowly from the eye, thus prolonging duration of action. Small molecular weight + higher molar doses + high drug concentration gradient between the vitreous and retina may support support superior drug distribution into the retina.


Adertise Here

Write to us at eophtha@gmail.com


Also read

50% in Ophthalmology in Facts & Figures Compiled by Dr. Md. Shahid Alam

Eponyms Derooted : Signs associated with Thyroid Eye Disease compiled by Dr. Rohit Rao

One-Liners in Ophthalmology Compiled and Created by Dr. Parthopratim Dutta Majumder

eOphtha Archive : Popular Reads

25 Basic Questions from Residents to The Academic Directors of Three Premier Eye Care Institutes in India

Residency in ophidirectorthalmology is getting tougher by the day. During the tenure of residency, one is filled with innumerable questions which they feel someone could help them with. This collated questionnaire is an effort in that front. It has a few relevant and common questions which a resident in ophthalmology faces every day. And who better than the heads of education of the top three ophthalmology institutes of the country to answer these questions.  We have the three doyens of academics answering and guiding the basic queries during residency program.  Dr. Venkatesh Prajna (DR NPV), Chief of Medical Education of Aravind Eye Hospital & Post Graduate Institute of Ophthalmology; Dr. Avinash Pathengay (Dr. AP), Director of the GMRV campus and Director of Academics of LVPEI network and Dr. S. Meenakshi Swaminathan (Dr MS), Director of Academics at Sankara Nethralaya  are here to answer few of our queries. Read the interview


Authorship by Dr. Bipasha Mukharjee

AuthorshipPublications represent the three ‘R’s of modern times– recognition, respect and revenue, for anyone in the field of science and research. Authorship has become the currency of the current generation and a measure of one's status in the international scientific community. The number of papers published, the journals in which they are published, and their ranking on the list of authors are all crucial when it comes to promotions, funding and market value in the employment exchange. The ‘publish or perish’ culture has become our survival mantra. However, as Rennie, Deputy Editor of the Journal of the American Medical Association put it: “the coin of publication has two sides: credit and accountability.”  Read more...


How to Present a Scientific Paper by Dr. Jyotirmay Biswas

micpodiumIt's true that Computer is indeed a boon to a scientist making a presentation. Yet it is important that the presenter himself is adequately prepared for a good presentation. He needs to plan carefully and follow a few basic steps.
A good scientific presentation starts from the time a paper is conceived. If you want to present a good paper, ensure that the concept is good, well thought, designed aptly, results well analysed and valid conclusions are made. You should have your ground work done and write the draft of the paper, before embarking on a presentation. A well-written draft will provide the frame work of a good presentation. Read more.....


A(VAST)IN Saga by Dr. Bikramjit Pal & Dr. Parthpratim Dutta Majumder

Vascular endothelial growth factor (VEGF)-A is a key mediator of angiogenesis. The discovery of VEGF-A, like many other major discoveries in medicine, happened partly by observations and partly by chance. Napoleone Ferrara and his team were working on a population of non-hormone-secreting cells from the anterior pituitary of cows. (1) One day Ferrara mixed some isolates from cultures of follicular cells with endothelial cells.  Read more....

Submit your ideas, write-up ; Be a part of eOphtha

Want to write for us !! Mail us your write-up at eophtha@gmail.com or whatsapp us at 9176034467